XOM
165.15
+2.47%↑
CVX
206.77
+0.92%↑
SHEL.US
91.2
+0.51%↑
TTE.FR
77.21
+1.42%↑
COPNY
129.36
+1.59%↑
XOM
165.15
+2.47%↑
CVX
206.77
+0.92%↑
SHEL.US
91.2
+0.51%↑
TTE.FR
77.21
+1.42%↑
COPNY
129.36
+1.59%↑
XOM
165.15
+2.47%↑
CVX
206.77
+0.92%↑
SHEL.US
91.2
+0.51%↑
TTE.FR
77.21
+1.42%↑
COPNY
129.36
+1.59%↑
XOM
165.15
+2.47%↑
CVX
206.77
+0.92%↑
SHEL.US
91.2
+0.51%↑
TTE.FR
77.21
+1.42%↑
COPNY
129.36
+1.59%↑
XOM
165.15
+2.47%↑
CVX
206.77
+0.92%↑
SHEL.US
91.2
+0.51%↑
TTE.FR
77.21
+1.42%↑
COPNY
129.36
+1.59%↑
24u
Huidig
Min
2.54
Max
2.7199999999999998
Inkomsten | -8.5M -17M |
|---|---|
Verkoop | 2K 27M |
EPS | -1.14 |
Winstmarge | -63.717 |
Werknemers | 323 |
EBITDA | -8.2M -16M |
Volgende Winsten | 26 mrt 2026 |
|---|
Marktkapitalisatie | -48M 50M |
|---|---|
Vorige openingsprijs | 7.04 |
Vorige sluitingsprijs | 2.55 |
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
23 mrt 2026, 23:47 UTC
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update
DJ
Lezen
23 mrt 2026, 22:55 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
DJ
Lezen
23 mrt 2026, 21:51 UTC
Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update
DJ
Lezen
23 mrt 2026, 23:59 UTC
Global Equities Roundup: Market Talk
DJ
Lezen
23 mrt 2026, 23:59 UTC
Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk
DJ
Lezen
23 mrt 2026, 23:50 UTC
Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk
DJ
Lezen
23 mrt 2026, 23:37 UTC
Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk
DJ
Lezen
23 mrt 2026, 22:42 UTC
Global Equities Roundup: Market Talk
DJ
Lezen
23 mrt 2026, 22:42 UTC
Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk
DJ
Lezen
23 mrt 2026, 22:40 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18B
DJ
Lezen
23 mrt 2026, 22:23 UTC
Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk
DJ
Lezen
23 mrt 2026, 22:22 UTC
Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease
DJ
Lezen
23 mrt 2026, 22:21 UTC
Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales
DJ
Lezen
23 mrt 2026, 22:21 UTC
Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China
DJ
Lezen
23 mrt 2026, 22:20 UTC
Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD
DJ
Lezen
23 mrt 2026, 22:20 UTC
Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD
DJ
Lezen
23 mrt 2026, 22:19 UTC
Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders
DJ
Lezen
23 mrt 2026, 22:19 UTC
Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets
DJ
Lezen
23 mrt 2026, 22:18 UTC
Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD
DJ
Lezen
23 mrt 2026, 22:15 UTC
Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD
DJ
Lezen
23 mrt 2026, 22:08 UTC
Ebos Needs to Reset Its Gearing Targets -- Market Talk
DJ
Lezen
23 mrt 2026, 21:42 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Lezen
23 mrt 2026, 21:42 UTC
RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk
DJ
Lezen
23 mrt 2026, 21:32 UTC
WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK
DJ
Lezen
23 mrt 2026, 21:32 UTC
WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK
DJ
Lezen
23 mrt 2026, 21:32 UTC
WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK
DJ
Lezen
23 mrt 2026, 21:10 UTC
Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com
DJ
Lezen
23 mrt 2026, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Lezen
23 mrt 2026, 20:50 UTC
Health Care Roundup: Market Talk
DJ
Lezen
23 mrt 2026, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Lezen
Prijswijziging
By TipRanks
0 ratings
0
Buy
0
Hold
0
Sell
Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Skillz Inc (Class A) - Dist in de afgelopen 3 maanden.
Verkoop- en administratiekosten
Bedrijfskosten
Winst voor belastingen
Verkoop
Kosten van verkopen
Brutowinst op verkopen
Rente-uitgaven op schulden
EBITDA
Operationele winst
$